3 Stocks That Could Trend Higher Soon: Monopar Therapeutics (MNPR), Cardiol Therapeutics (CRDL), InfuSystem (INFU)
As the sector evolves, the transition from research-driven narratives to execution-focused strategies is becoming increasingly pronounced. Companies are now expected to demonstrate not only scientific credibility but also the ability to navigate complex regulatory pathways and prepare for eventual market entry. This broader shift underscores a growing recognition that sustainable value creation in biotechnology depends … Read more